Heart and heart-lung transplantation in adults with congenital heart disease

Cindy M. Martin, James H. Moller

Research output: Chapter in Book/Report/Conference proceedingChapter


Because of cardiac operations in children, more than a million adults with treated congenital heart disease survive. Those with complex anomalies, which may have been palliated, develop cardiac failure which may become resistant to medical treatment. For these patients heart or heart-lung transplantation offers an approach. In this chapter the indications and the UNOS classification for considering patients for transplantation are presented. Two factors may limit classification: inability to determine pulmonary vascular resistance in those with more than one source of pulmonary blood flow and secondly elevated HLA antibody levels from previous cardiac operations. There are unique factors that patients experience postoperatively, but 10-year survival is favorable.

Original languageEnglish (US)
Title of host publicationCongestive Heart Failure and Cardiac Transplantation
Subtitle of host publicationClinical, Pathology, Imaging and Molecular Profiles
PublisherSpringer International Publishing
Number of pages9
ISBN (Electronic)9783319445779
ISBN (Print)9783319445755
StatePublished - Jun 1 2017


  • Adults
  • CHD
  • Congenital heart disease
  • Heart transplantation
  • Heart-lung transplantation

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Heart and heart-lung transplantation in adults with congenital heart disease'. Together they form a unique fingerprint.

Cite this